医療産業における人工知能(AI)のアジア市場予測

◆英語タイトル:ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET FORECAST 2017-2025
◆商品コード:INKW711003
◆発行会社(調査会社):Inkwood Research
◆発行日:2017年10月
◆ページ数:69
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:アジア
◆産業分野:IT
◆販売価格オプション(消費税別)
Single UserUSD1,250 ⇒換算¥132,500見積依頼/購入/質問フォーム
Multi LicenseUSD1,500 ⇒換算¥159,000見積依頼/購入/質問フォーム
Enterprisewide Price (Global Site License)USD2,000 ⇒換算¥212,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
【レポートの概要】

KEY FINDINGSAsia Pacific artificial intelligence in healthcare market which was valued at $254 million in 2016 is predicted to grow with an estimated CAGR of 40.47% over the forecast period of 2017-2025.
MARKET INSIGHTS
The Asia-Pacific market is slated to showcase the fastest growth over the forecast period. Factors like positive economic outlook, increasing internet penetration into the market and the rising healthcare expenditure are driving the Asia-Pacific market. The market is primarily segmented on the basis of technology, offering, application and end users. However, the slow adoption of AI-based technologies and the ambiguous regulatory guidelines for medical software are restraining the market growth.
COMPETITIVE INSIGHTS
iCarbonX, GE Healthcare, Welltok Inc, Oncore Medical Inc, International Business Machines (IBM) Corporation, Microsoft Corporation, Intel Corporation and Google Inc are some of the major players in this market.

【レポートの目次】

1. RESEARCH SCOPE
1.1. STUDY GOALS
1.2. SCOPE OF THE MARKET STUDY
1.3. WHO WILL FIND THIS REPORT USEFUL?
1.4. STUDY AND FORECASTING YEARS
2. RESEARCH METHODOLOGY
2.1. SOURCES OF DATA
2.1.1. SECONDARY DATA
2.1.2. PRIMARY DATA
2.2. TOP-DOWN APPROACH
2.3. BOTTOM-UP APPROACH
2.4. DATA TRIANGULATION
3. EXECUTIVE SUMMARY
3.1. MARKET SUMMARY
3.2. KEY FINDINGS
3.2.1. LARGE SCALE INVESTMENT IN THE ARTIFICIAL INTELLIGENCE MARKET
3.2.2. DEEP LEARNING SHOWS A LARGE DEMAND IN THE ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
4. MARKET DYNAMICS
4.1. ETYMOLOGY OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
4.2. MARKET DEFINITION AND SCOPE
4.3. INDUSTRY COMPONENTS
4.3.1. ARTIFICIAL INTELLIGENCE ANALYSIS
4.3.2. DATA WAREHOUSE
4.3.3. SOFTWARE DEVELOPMENT
4.4. LEGAL, POLICY AND REGULATORY ISSUES
4.5. MARKET DRIVERS
4.5.1. RISE IN BIG DATA IN HEALTHCARE INDUSTRY
4.5.2. EMERGENCE OF PERSONALIZED MEDICINE IN TESTS FOR CLINICAL DECISION MAKING
4.5.3. INCREASING ADOPTION OF ARTIFICIAL INTELLIGENCE (AI) IN GENETICS
4.5.4. AI CREATING A REAL-TIME MONITORING SYSTEM
4.5.5. HEALTHCARE WEARABLES PLAYING AN IMPORTANT ROLE IN MONITORING
4.6. MARKET RESTRAINTS
4.6.1. SLOW ADOPTION OF AI BASED TECHNOLOGIES
4.6.2. AMBIGUOUS REGULATORY GUIDELINES FOR MEDICAL SOFTWARE
4.7. MARKET OPPORTUNITIES
4.7.1. HEALTHCARE WORKER TO PATIENT RATIO BEING BALANCED WITH AI
4.7.2. USE OF AI IN INNOVATIVE SURGERIES
4.7.3. INTEGRATION WITH EXISTING SYSTEMS
4.8. MARKET CHALLENGES
4.8.1. LACK OF USABLE DATA IN HEALTHCARE
4.8.2. CHALLENGE TO MAINTAIN DATA SECURITY
5. MARKET BY OFFERING
5.1. HARDWARE
5.2. SOFTWARE
5.3. SERVICES
6. MARKET BY TECHNOLOGY
6.1. CONTEXT AWARE PROCESSING
6.2. DEEP LEARNING
6.3. NATURAL LANGUAGE PROCESSING
6.4. QUERYING METHOD
7. MARKET BY APPLICATION
7.1. DRUG DISCOVERY
7.2. INPATIENT CARE & HOSPITAL MANAGEMENT
7.3. LIFESTYLE MANAGEMENT & MONITORING
7.4. MEDICAL IMAGING & DIAGNOSTICS
7.5. PATIENT DATA & RISK ANALYSIS
7.6. PRECISION MEDICINE
7.7. RESEARCH
7.8. VIRTUAL ASSISTANT
7.9. WEARABLES
8. MARKET BY END USERS
8.1. ACOS & MCOS
8.2. PATIENTS
8.3. PAYERS
8.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.5. PROVIDERS
9. KEY ANALYTICS
9.1. PORTER”S FIVE FORCE ANALYSIS
9.1.1. THREAT OF NEW ENTRANTS
9.1.2. THREAT OF SUBSTITUTE
9.1.3. BARGAINING POWER OF SUPPLIERS
9.1.4. BARGAINING POWER OF BUYERS
9.1.5. INTENSITY OF COMPETITIVE RIVALRY
9.2. OPPORTUNITY MATRIX
9.3. KEY BUYING CRITERIA
9.3.1. APPLICATION
9.3.2. TECHNOLOGY
9.3.3. INTEGRATION WITH EXISTING INFRASTRUCTURE
9.4. INVESTMENT ANALYSIS
9.4.1. FASTEST GROWING REVENUE SEGMENT-WISE OPPORTUNITIES
10. GEOGRAPHICAL ANALYSIS
10.1. CHINA
10.2. JAPAN
10.3. INDIA
10.4. AUSTRALIA
10.5. REST OF ASIA PACIFIC
11. COMPETITIVE LANDSCAPE
11.1. MARKET SHARE ANALYSIS
11.2. TOP 5 COMPANIES
11.2.1. GOOGLE INC
11.2.2. INTERNATIONAL BUSINESS MACHINES (IBM) CORPORATION
11.2.3. INTEL CORPORATION
11.2.4. MICROSOFT CORPORATION
11.2.5. GE HEALTHCARE
11.3. KEY STRATEGIES
11.3.1. PRODUCT LAUNCH
11.3.2. PARTNERSHIP & COLLABORATION
11.3.3. MERGER & ACQUISITION
11.3.4. INVESTMENTS
11.3.5. EXPANSIONS
11.4. COMPANY PROFILES
11.4.1. DEEP GENOMICS INC.
11.4.1.1. OVERVIEW
11.4.1.2. PRODUCT PORTFOLIO
11.4.1.3. STRATEGIC INITIATIVES
11.4.1.4. SCOT ANALYSIS
11.4.2. ENLITIC INC.
11.4.2.1. OVERVIEW
11.4.2.2. PRODUCT PORTFOLIO
11.4.2.3. STRATEGIC INITIATIVES
11.4.2.4. SCOT ANALYSIS
11.4.3. GE HEALTHCARE
11.4.3.1. OVERVIEW
11.4.3.2. PRODUCT PORTFOLIO
11.4.3.3. STRATEGIC INITIATIVES
11.4.3.4. SCOT ANALYSIS
11.4.4. GENERAL VISION INC
11.4.4.1. OVERVIEW
11.4.4.2. PRODUCT PORTFOLIO
11.4.4.3. STRATEGIC INITIATIVES
11.4.4.4. SCOT ANALYSIS
11.4.5. GOOGLE INC
11.4.5.1. OVERVIEW
11.4.5.2. PRODUCT PORTFOLIO
11.4.5.3. STRATEGIC INITIATIVES
11.4.5.4. SCOT ANALYSIS
11.4.6. INTERNATIONAL BUSINESS MACHINES CORPORATION (IBM)
11.4.6.1. OVERVIEW
11.4.6.2. PRODUCT PORTFOLIO
11.4.6.3. STRATEGIC INITIATIVES
11.4.6.4. SCOT ANALYSIS
11.4.7. ICARBONX
11.4.7.1. OVERVIEW
11.4.7.2. PRODUCT PORTFOLIO
11.4.7.3. STRATEGIC INITIATIVES
11.4.7.4. SCOT ANALYSIS
11.4.8. INTEL CORPORATION
11.4.8.1. OVERVIEW
11.4.8.2. PRODUCT PORTFOLIO
11.4.8.3. STRATEGIC INITIATIVES
11.4.8.4. SCOT ANALYSIS
11.4.9. MICROSOFT CORPORATION
11.4.9.1. OVERVIEW
11.4.9.2. PRODUCT PORTFOLIO
11.4.9.3. STRATEGIC INITIATIVES
11.4.9.4. SCOT ANALYSIS
11.4.10. NEXT IT CORPORATION
11.4.10.1. OVERVIEW
11.4.10.2. PRODUCT PORTFOLIO
11.4.10.3. STRATEGIC INITIATIVES
11.4.10.4. SCOT ANALYSIS
11.4.11. NVIDIA CORPORATION
11.4.11.1. OVERVIEW
11.4.11.2. PRODUCT PORTFOLIO
11.4.11.3. STRATEGIC INITIATIVES
11.4.11.4. SCOT ANALYSIS
11.4.12. ONCORE MEDICAL INC.
11.4.12.1. OVERVIEW
11.4.12.2. PRODUCT PORTFOLIO
11.4.12.3. STRATEGIC INITIATIVES
11.4.12.4. SCOT ANALYSIS
11.4.13. RECURSION PHARMACEUTICALS INC.
11.4.13.1. OVERVIEW
11.4.13.2. PRODUCT PORTFOLIO
11.4.13.3. STRATEGIC INITIATIVES
11.4.13.4. SCOT ANALYSIS
11.4.14. STRYKER CORPORATION
11.4.14.1. OVERVIEW
11.4.14.2. PRODUCT PORTFOLIO
11.4.14.3. STRATEGIC INITIATIVES
11.4.14.4. SCOT ANALYSIS
11.4.15. WELLTOK INC
11.4.15.1. OVERVIEW
11.4.15.2. PRODUCT PORTFOLIO
11.4.15.3. STRATEGIC INITIATIVES
11.4.15.4. SCOT ANALYSIS

TABLE LIST
TABLE 1: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2017-2025 (IN $ MILLION)
TABLE 2: REGULATORY FRAMEWORK OF AI IN HEALTHCARE MARKET
TABLE 3: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERINGS, 2017-2025 (IN $ MILLION)
TABLE 4: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2017-2025 (IN $ MILLION)
TABLE 5: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2017-2025 (IN $ MILLION)
TABLE 6: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2017-2025 (IN $ MILLION)
TABLE 7: OPPORTUNITY MATRIX FOR ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 8: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2017-2025 (IN $ MILLION)
TABLE 9: LIST OF PRODUCT LAUNCHES IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 10: LIST OF PARTNERSHIP & COLLABORATION IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 11: LIST OF MERGER & ACQUISITION IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 12: LIST OF INVESTMENTS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
TABLE 13: LIST OF EXPANSIONS IN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET

FIGURE LIST
FIGURE 1: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2016 & 2025 (IN $ MILLION)
FIGURE 2: GROWTH OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE
FIGURE 3: INDUSTRY COMPONENTS
FIGURE 4: INCREASING INTERNET USERS IN ASIA PACIFIC (% OF POPULATION)
FIGURE 5: HEALTHCARE IOT DEVICES INSTALLATIONS
FIGURE 6: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY OFFERINGS, 2016 & 2025 (IN $ MILLION)
FIGURE 7: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY HARDWARE, 2017-2025 (IN $ MILLION)
FIGURE 8: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY SOFTWARE, 2017-2025 (IN $ MILLION)
FIGURE 9: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY SERVICES, 2017-2025 (IN $ MILLION)
FIGURE 10: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY TECHNOLOGY, 2016 & 2025 (IN $ MILLION)
FIGURE 11: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY CONTEXT AWARE PROCESSING, 2017-2025 (IN $ MILLION)
FIGURE 12: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY DEEP LEARNING, 2017-2025 (IN $ MILLION)
FIGURE 13: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY NATURAL LANGUAGE PROCESSING, 2017-2025 (IN $ MILLION)
FIGURE 14: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY QUERYING METHOD, 2017-2025 (IN $ MILLION)
FIGURE 15: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY APPLICATION, 2016 & 2025 (IN $ MILLION)
FIGURE 16: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY DRUG DISCOVERY, 2017-2025 (IN $ MILLION)
FIGURE 17: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY INPATIENT CARE & HOSPITAL MANAGEMENT, 2017-2025 (IN $ MILLION)
FIGURE 18: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY LIFESTYLE MANAGEMENT & MONITORING, 2017-2025 (IN $ MILLION)
FIGURE 19: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY MEDICAL IMAGING & DIAGNOSTICS, 2017-2025 (IN $ MILLION)
FIGURE 20: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PATIENT DATA & RISK ANALYSIS, 2017-2025 (IN $ MILLION)
FIGURE 21: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PRECISION MEDICINE, 2017-2025 (IN $ MILLION)
FIGURE 22: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY RESEARCH, 2017-2025 (IN $ MILLION)
FIGURE 23: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY VIRTUAL ASSISTANT, 2017-2025 (IN $ MILLION)
FIGURE 24: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY WEARABLES, 2017-2025 (IN $ MILLION)
FIGURE 25: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY END USERS, 2016 & 2025 (IN $ FIGURE)
FIGURE 26: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY ACOS & MCOS, 2017-2025 (IN $ MILLION)
FIGURE 27: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PATIENTS, 2017-2025 (IN $ MILLION)
FIGURE 28: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PAYERS, 2017-2025 (IN $ MILLION)
FIGURE 29: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2017-2025 (IN $ MILLION)
FIGURE 30: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY PROVIDERS, 2017-2025 (IN $ MILLION)
FIGURE 31: PORTER’S FIVE FORCE MODEL OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET
FIGURE 32: KEY BUYING IMPACT ANALYSIS
FIGURE 33: INVESTMENT ANALYSIS OF ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET IN 2016, BY FASTEST GROWING REVENUE SEGMENTS
FIGURE 34: ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, BY COUNTRY, 2016 & 2025 (IN %)
FIGURE 35: CHINA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 36: JAPAN ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 37: INDIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 38: AUSTRALIA ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 39: REST OF ASIA PACIFIC ARTIFICIAL INTELLIGENCE IN HEALTHCARE MARKET, 2017-2025 (IN $ MILLION)
FIGURE 40: MARKET SHARE ANALYSIS OF TOP PLAYERS IN 2016 (%)



★調査レポート[医療産業における人工知能(AI)のアジア市場予測] (コード:INKW711003)販売に関する免責事項を必ずご確認ください。
★調査レポート[医療産業における人工知能(AI)のアジア市場予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆